Fulcrum Therapeutics (FULC) Retained Earnings (2018 - 2026)
Fulcrum Therapeutics' (FULC) quarterly Retained Earnings came in at -$513000.0 in Q1 2026, up 99.9% year-on-year from -$256622.6 in Q1 2025, and up 99.91% on a QoQ basis from -$594.3 million in Q4 2025.
Fulcrum Therapeutics (FULC) Retained Earnings (2018 - 2026) Analysis & Trends
Fulcrum Therapeutics (FULC) has 9 years of Retained Earnings data on file, last reported at -$513000.0 in Q1 2026.
- On a quarterly basis, Retained Earnings rose 99.9% year-over-year to -$513000.0 in Q1 2026; TTM through Mar 2026 was -$513000.0, a 99.9% increase from a year earlier, with the FY2025 full-year figure at -$594.3 million, down 457236.92% from the prior year.
- Retained Earnings for Q1 2026 stood at -$513000.0, up from -$594.3 million in the prior quarter.
- Over the last five years, Retained Earnings for FULC reached as high as $130000.0 in Q4 2024 and fell as low as -$594.3 million in Q4 2025.
- Historically, Retained Earnings has averaged -$239.6 million across 5 years, with a median of -$1.2 million in 2023.
- Across the five-year window, Retained Earnings jumped 195.59% in 2024 and sank 457236.92% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$797000.0 in 2022, then surged by 82.94% to -$136000.0 in 2023, then soared by 195.59% to $130000.0 in 2024, then sank by 457236.92% to -$594.3 million in 2025, then jumped by 99.91% to -$513000.0 in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$513000.0 in Q1 2026, -$594.3 million in Q4 2025, and -$573.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Fulcrum Therapeutics | 286.57 Mn | 286.57 Mn | - | -513,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -513,000.00 |
| Dec 31, 2025 | -594.28 Mn |
| Sep 30, 2025 | -573.90 Mn |
| Jun 30, 2025 | -554.35 Mn |
| Mar 31, 2025 | -537.10 Mn |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | -502.80 Mn |
| Jun 30, 2024 | -481.10 Mn |
| Mar 31, 2024 | -434,000.00 |
| Dec 31, 2023 | -136,000.00 |
| Sep 30, 2023 | -886,000.00 |
| Jun 30, 2023 | -1.20 Mn |
| Mar 31, 2023 | -437.12 Mn |
| Dec 31, 2022 | -797,000.00 |
| Sep 30, 2022 | -386.20 Mn |
| Jun 30, 2022 | -1.07 Mn |
| Mar 31, 2022 | -1.09 Mn |
| Dec 31, 2021 | -302.47 Mn |
| Sep 30, 2021 | -278.98 Mn |
| Jun 30, 2021 | -258.27 Mn |